13F Holdings
中文EN

SINT Sintx Technologies, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1269026 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY160.8%
TTM net income YoY5.2%
TTM EPS YoY13.0%
Revenue 3-yr CAGR10.0%
Net income 3-yr CAGR—

Margins

Gross margin59.5%
Operating margin-303.4%
Net margin-281.9%
FCF margin-279.2%
EBITDA margin-295.3%

Returns

ROE-250.4%
ROA-92.1%
ROIC (approx.)—
Asset turnover0.33x

Leverage & solvency

Liabilities / assets61.9%
Debt / equity0.00x
Current ratio1.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.96x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue8.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.19M$452,000$380,000$290,000$208,000$151,000$369,000$542,000
Cost of revenue$828,000$174,000$236,000$102,000$115,000$94,000$246,000$154,000
Gross profit$1.36M$278,000$144,000$188,000$93,000$57,000$123,000$388,000
R&D expense$548,000$573,000$364,000$969,000$1.26M$1.24M$1.12M$709,000
SG&A expense$2.25M$2.32M$2.54M$1.36M$2.10M$1.42M$1.32M$1.00M
Operating income-$1.64M-$2.89M-$3.21M-$2.32M-$3.35M-$2.67M-$2.38M-$1.73M
Pretax income-$1.59M-$2.71M-$2.82M-$2.21M-$3.54M-$2.32M-$2.29M-$1.70M
Net income-$1.59M-$2.71M-$2.82M-$2.21M-$3.54M-$2.32M-$2.29M-$1.70M
EBITDA-$1.57M-$2.82M-$3.14M-$2.24M-$3.28M-$2.59M-$2.29M-$1.62M
EPS (basic)-0.24-0.75-0.70—-3.46-0.91-1.29—
EPS (diluted)-0.24-0.75-0.70—-3.46-0.91-1.29—
Weighted avg. shares (diluted)6.67M4.85M4.01M—2.96M2.54M1.77M—
Banking
Deposits————$1.80M$750,000——
Balance sheet
Cash & equivalents$2.00M$3.59M$1.89M$4.14M$6.25M$4.32M$6.50M$3.60M
Inventory$2.56M$2.25M$1.39M$825,000$447,000$355,000$425,000$502,000
Current assets$5.52M$7.03M$4.32M$5.65M$7.39M$5.55M$7.62M$4.52M
PP&E, net$518,000$434,000$415,000$476,000$507,000$499,000$575,000$922,000
Goodwill$302,000$302,000$302,000$302,000$302,000———
Intangibles$116,000$125,000$133,000$142,000$150,000$14,000$15,000$16,000
Total assets$8.90M$10.43M$7.81M$9.51M$11.36M$9.20M$11.45M$9.41M
Current liabilities$3.00M$2.98M$4.17M$3.73M$4.35M$2.16M$2.21M$1.98M
Short-term debt$55,000$102,000$106,000$7,000$59,000$109,000$131,000$32,000
Total liabilities$5.51M$5.60M$6.91M$6.58M$7.30M$5.21M$5.36M$5.52M
Shareholders' equity$3.39M$4.83M$904,000$2.93M$4.07M$3.99M$6.09M$3.89M
Shares outstanding6.89M6.61M4.12M3.97M3.62M2.49M2.49M1.34M
Cash flow statement
Operating cash flow-$1.37M-$2.77M-$2.49M-$2.34M-$2.52M-$2.41M-$1.30M-$1.12M
Capital expenditure$144,000$84,000$7,000$42,000$84,000$0$59,000$146,000
Free cash flow-$1.51M-$2.85M-$2.50M-$2.39M-$2.60M-$2.41M-$1.36M-$1.27M
Investing cash flow-$144,000-$84,000-$7,000-$42,000$666,000$352,000-$63,000$10,000
Financing cash flow-$72,000$4.55M$247,000$276,000$3.78M-$123,000$4.27M-$102,000
Depreciation & amortization$61,000$64,000$68,000$74,000$74,000$76,000$95,000$115,000
Stock-based compensation$275,000$317,000$530,000$651,000$546,000$175,000$18,000$7,000
Share buybacks———$0$0$47,000$86,000—

Free plan shows the latest 8 periods; Pro shows all 55 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.